Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1

Biochemical and Biophysical Research Communications

Volumn 456, Issue 3, 2015, Pages 815-820

  Zhou, Heng ^a   Guo, Wei ^a   Long, Cong ^a   Wang, Huan ^a   Wang, Jingchao ^a   Sun, Xiaoping ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

B lymphocytes; EBV; ED L1; LMP1; Triptolide

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; LATENT MEMBRANE PROTEIN 1; LUCIFERASE; MESSENGER RNA; TRIPTOLIDE; ANTINEOPLASTIC AGENT; DITERPENE; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; EPOXIDE; MATRIX PROTEIN; PHENANTHRENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; INFECTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS INHIBITION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; LYMPHOMA, B-CELL; PATHOLOGY; PROMOTER REGION; TUMOR CELL LINE; VIROLOGY;

HUMAN HERPESVIRUS 4; MUS MUSCULUS; TRIPTERYGIUM;

ANIMALS; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; DITERPENES; DOWN-REGULATION; EPOXY COMPOUNDS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; PHENANTHRENES; PROMOTER REGIONS, GENETIC; VIRAL MATRIX PROTEINS;

EID: 84920725748     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.12.023     Document Type: Article

References (24)

1. E.D. Kieff, and A.B. Rickinson Epstein-Barr Virus and Its Replication 2007 fifth ed. Fields Virology 2604-2654
2. K.M. Kaye, K.M. Lzumi, and E. Kieff Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation Proc. Natl. Acad. Sci. 90 1993 9150 9154
3. K. Ellen, K. Arnd, and H. Wolfgang Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor EMBO 17 1998 1700 1709
4. N.J. Thornburg, W. Kulwichit, and N. Raab-Traub LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice Oncogene 25 2006 288 297
5. B.C. Zhang, S. Kracker, and K. Rajewsky Immune surveillance and therapy of lymphomas driven by Epstein-Barr-virus protein LMP1 in a mouse model Cell 148 2012 739 751
6. N. Ahsan, T. Kanda, and K. Takada Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production J. Virol. 79 2005 4415 4424
7. H.L. Chen, J.M. Lee, and S.D. Hayward Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors J. Virol. 75 2001 2929 2937
8. S.R. Grossman, E. Johannsen, and E.D. Kieff The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein Proc. Natl. Acad. Sci. 91 1994 7568 7572
9. C. Noda, T. Murata, and T. Tsurumi Identification and characterization of CCAAT enhancerbinding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1 J. Biol. Chem. 286 2011 42524 42533
10. A.M. Repic, M.X. Shi, and J.W. Sixbey Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeats J. Virol. 84 2010 2236 2244
11. K.F. Wong, Y. Yuan, and J.M. Luk Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents Clin. Exp. Pharmacol. Physiol. 39 2012 311 320
12. S. Banerjee, V. Sangwan, and A. Saluja Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1 J. Biol. Chem. 288 2013 33927 33938
13. P.A. Philips, V. Dudeja, and A.K. Saluja Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70 Cancer Res. 67 2007 9407 9416
14. V. Soni, and E. Kieff LMP1 TRAFficking activates growth and survival pathways Adv. Exp. Med. Biol. 597 2007 173 187
15. H. Zheng, L.L. Li, and Y. Cao Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma Cell. Mol. Immunol. 4 2007 185 196
16. W.W. Huang, T.T. He, and M. Lei Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression PLoS ONE 7 2012
17. D. Wang, D. Liebowitz, and E. Kieff An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells Cell 43 1985 831 840
18. Z.L. Zhou, Y.X. Yang, and Z.H. Miao Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents Nat. Prod. Rep. 29 2012 457 475
19. G.A. Bishop, and L.K. Busch Molecular mechanisms of B-lymphocyte transformation by Epstein-Barr virus Microbes Infect. 4 2002 853 857
20. X.P. Sun, E.A. Barlow, and S.C. Kenney Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism Proc. Natl. Acad. Sci. 107 2010 3146 3151
21. T. Murata, S. Lwata, and T. Tsurumi Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of Epstein-Barr virus-positive natural killer cell lymphoma PLoS ONE 8 2013
22. H.H. Niller, H. Wolf, and J. Minarovits Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases Autoimmunity 41 2008 298 328
23. L. Xiao, Z.Y. Hu, and Y. Cao Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy Oncogene 33 2014 4568 4578
24. J.M. Middeldorp, and D.M. Pegtel Multiple roles of LMP1 in Epstein-Barr virus induced immune escape Semin. Cancer Biol. 18 2008 388 396